Luc J. Jordaens and Dominic A.M.J. Theuns

2007

Clinical Management and Case Reports

Implantable cardioverter-defibrillator (ICD) therapy is one of the most important advances in the therapeutic approach of cardiovascular patients, with a life saving benefit exceeding that of all antiarrhythmic drugs. Since the first defibrillator implantation in 1980, the technology, diagnostic and therapeutic options have dramatically evolved, widening the indication area from secondary to primary prevention of sudden cardiac death.